Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Association between prediabetes and depression: A meta-analysis

  • Yi Yu ,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing – original draft, Writing – review & editing

    ‡ YY and WW are contributed equally to this work and share first authorship on this work.

    Affiliation Department of Psychiatry, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China

    ⨯
  • Weitao Wan

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Supervision, Writing – original draft, Writing – review & editing

    wwt686@sohu.com

    ‡ YY and WW are contributed equally to this work and share first authorship on this work.

    Affiliation Department of Psychiatry, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China

    ⨯

Abstract

Background

Previous studies evaluating the association between prediabetes and depression have shown inconsistent results. Consequently, the aim of the systematic review and meta-analysis was to investigate whether prediabetes is associated with depression in the general population.

Methods

Relevant observational studies were obtained by searching the Medline, Web of Science, and Embase databases. A random-effects model was utilized to pool the results by incorporating the influence of heterogeneity. Multiple subgroup analysis was performed to evaluate the influence of the study characteristics on the outcome.

Results

Sixteen large-scale cross-sectional studies involving 322,863 participants were included. Among the total participants, 82,154 (25.4%) had prediabetes. The pooled results showed that prediabetes was associated with a higher prevalence of depression in this population (odds ratio [OR]: 1.16, 95% confidence interval [CI]: 1.05 to 1.28, p = 0.003; I2 = 58%). Subgroup analysis showed a stronger association between prediabetes and depression in younger subjects (<50 years old, OR: 1.25, 95% CI: 1.04 to 1.50) than that in older subjects (≥50 years old, OR: 1.05, 95% CI: 1.10 to 1.10; p for subgroup difference = 0.03). Other study characteristics, such as the study country, sex of the participants, definition of prediabetes, methods for the detection of depression, and study quality score, did not seem to significantly affect the results (p for subgroup difference all > 0.05).

Conclusions

Prediabetes may be associated with a slightly higher prevalence of depression in the general population, particularly in subjects aged <50 years old.

Citation: Yu Y, Wan W (2024) Association between prediabetes and depression: A meta-analysis. PLoS ONE 19(8): e0307428. https://doi.org/10.1371/journal.pone.0307428

Editor: Anselm J. M. Hennis, PAHO/WHO, UNITED STATES OF AMERICA

Received: February 24, 2024; Accepted: July 4, 2024; Published: August 22, 2024

Copyright: © 2024 Yu, Wan. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: The authors confirm that the data supporting the findings of this study are available within the article.

Funding: The author(s) received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Depression is a common affective disorder in patients with chronic diseases [1–3]. As a common metabolic disorder, the prevalence of diabetes has increased in recent decades in both developing and developed countries [4]. Accumulating evidence suggests that people with diabetes have an increased risk of depression [5, 6]. In a previous meta-analysis, it was shown that approximately more than half of patients with diabetes suffer from depression [7]. In children and adolescents with type 1 diabetes, the pooled prevalence of depression was reported to be nearly 30% [8]. Interestingly, subsequent studies suggest that the association between diabetes and depression seems to be bidirectional [9–11]. Besides a high prevalence of depression in patients with diabetes, it is also shown that various measures of depression could be used to predict the risk of type 2 diabetes, such as depression as evidenced by symptom scales, patient diagnosis, face-to-face interviews, and the use of antidepressants [12]. With the recent research advances in the field of diabetology, an intermediate state of hyperglycemia between normoglycemia and diabetes has been proposed, which is termed as prediabetes [13, 14]. Clinically, prediabetes refers to the status of impaired glucose regulation before a diagnosis of diabetes, which includes impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and mildly elevated glycolated hemoglobin (HbA1c: 5.7% to 6.4%) [15]. Similar to diabetes, people with prediabetes have also been associated with an increased risk of cardiovascular diseases [16]. In view of the close relationship between diabetes and depression, it is interesting to determine if prediabetes is also associated with depression in the general population [17]. However, the results of previous studies were not consistent [18–33]. Some of them supported that prediabetes was related to depression [24–27, 29, 30], while other studies did not found a statistically significant association [18–23, 28, 31–33]. In addition, these studies are with populations from various places and of different study definitions and methodologies for evaluating prediabetes and depression [18–33]. It remains unknown whether these factors may influence the association between prediabetes and depression. Consequently, in this study, we performed a systematic review and meta-analysis to investigate whether prediabetes is associated with depression in the general population.

Methods

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) [34, 35] and the Cochrane Handbook for Systematic Reviews and Meta-analyses [36] were followed in this meta-analysis during the study design, data collection, statistical analysis, and results interpretation.

Literature search

To identify studies relevant to the aim of the meta-analysis, we searched the Medline, Web of Science, and Embase databases utilizing comprehensive search terms involving: (1) "prediabetes" OR "pre-diabetes" OR "prediabetic" OR "pre-diabetic" OR "prediabetic state" OR "borderline diabetes" OR "impaired fasting glucose" OR "impaired glucose tolerance" OR "IFG" OR "IGT"; and (2) "depression" OR "depressive". The search terms were based on key words rather than MeSH terms to improve the sensitivity of the database search. However, a comparison with MeSH terms was performed before database search to ensure all relevant MeSH terms are included in the search terms.

Inclusion and exclusion criteria

The inclusion criteria for the potential studies were: (1) large-scale observational studies published as full-length articles (sample size ≥ 1000); (2) studies conducted in adults (18 years and older); (3) prediabetes and depression were evaluated with the same methods and diagnostic criteria in accordance with those used in the original studies; and (4) reported the prevalence/incidence of depression compared between participants with prediabetes versus normoglycemia in a multivariate analysis, as well at least adjusting for age and sex.

The exclusion criteria were: (1) small-scale studies, studies including patients who were diagnosed with specific diseases rather than a general population, or studies with univariate analysis; (2) studies did not evaluate prediabetes or did not report depression; or (3) preclinical studies, reviews, or editorials. If studies with overlapping populations were retrieved, the one with the largest sample size was included for the meta-analysis.

The search was limited to studies in humans. Also, we only considered studies published as full-length articles in peer-reviewed journals in English. In addition, the references of related original and review articles were also manually screened for identifying potentially related studies. The literatures published from the inception of the databases to December 8, 2023 were screened.

Study quality evaluation and data extraction

The processes for the literature search, study identification, study quality evaluation, and data collection were independently conducted by two authors. In case of disagreement, the two authors discussed it to reach a consensus. We used the Newcastle–Ottawa Scale (NOS) [37] for assessing the quality of the included studies. This scale consisted of three aspects, including selection of the population, control of confounders, and outcome measurement and analysis. The total NOS scores ranged from 1 to 9, with 9 indicating the best quality. The following data were extracted from each study for subsequent analysis: the study information (author, year, country, and design), participant characteristics (sample size, age, and sex), diagnosis of prediabetes (definition and number of participants with prediabetes), diagnosis of depression (methods and number of participants with depression), and variables adjusted when the association between prediabetes and depression was reported.

Statistics

The association between prediabetes and depression was summarized as the odds ratio (OR) and corresponding 95% confidence interval (CI). By using 95% CIs or p-values, the ORs and standard errors (SEs) could be calculated, while a subsequent logarithmical transformation kept the variance stabilized and normalized. The Cochrane Q test and I2 statistics were used to estimate study heterogeneity [38], with significant heterogeneity reflected by I2 > 50%. The results were combined using a random-effects model incorporating heterogeneity’s influence [36]. Sensitivity analyses by omitting one study at a time were performed to investigate the robustness of the findings. Predefined subgroup analyses were also performed to evaluate the influences of the study characteristics on the outcome. The medians of the continuous variables were used as the cutoffs for defining the subgroups. The estimation of publication bias underlying the meta-analysis was first achieved by construction of funnel plots and visual inspection of the plot symmetry [39]. An Egger’s regression test was also performed [39]. The statistical analysis was carried out using RevMan (Version 5.1; Cochrane Collaboration, Oxford, UK) and Stata software (version 12.0; Stata Corporation, College Station, TX). A two-sided p < 0.05 suggested statistical significance.

Results

Study inclusion

The process for identifying relevant studies for study inclusion in the meta-analysis is presented in Fig 1. In brief, 2032 potentially relevant records were obtained after comprehensive searches of the three databases, with 433 studies then excluded due to duplication. Subsequently, a screening via considering the titles and abstracts of the remaining records led to the exclusion of a further 1548 studies, mostly because they were not related to the aim of the meta-analysis, leaving 51 studies remaining. Accordingly, the full texts of the remaining 51 studies were read by two independent authors, and 35 of them were further removed for various reasons, as listed in Fig 1. Finally, 16 observational studies remained and were considered to be suitable for the subsequent quantitative analyses [18–33].

thumbnail
Download:
Fig 1. Flowchart depicting the database search and study inclusion processes.

https://doi.org/10.1371/journal.pone.0307428.g001

Overview of the study characteristics

Table 1 presents the summarized characteristics of the included studies. Overall, 16 cross-sectional studies [18–33] were included in the meta-analysis. These studies were reported from 2007 to 2023, and performed in Finland, the Netherlands, the United Kingdom, the United States, India, China, Bangladesh, Austria, and Korea. All of the studies had large sample sizes, ranging from 1,728 to 229,047. Community-derived general populations were included in all of the included studies except for one study, which enrolled US veterans [23]. The mean ages of the participants were 38.1 to 66.1 years old. As for the definition of prediabetes, IFG was used in three studies [18, 23, 24], IFG and/or IGT were used in ten studies [19–22, 25–27, 30–32], and IFG and/or increased HbA1c (5.7~6.4%) were used in the other three studies [28, 29, 33]. Accordingly, 82,154 (25.4%) of the included subjects had prediabetes. Various scales were used to identify people with depression, with the Patient Health Questionnaire 9 items (PHQ-9) the most commonly used, being applied in six studies [24, 27, 28, 31–33]. Multivariate analyses were used among all the included studies when the association between prediabetes and depression was reported, which at least accounted for potential confounding factors, such as age and sex. The NOS of the included studies were seven to nine stars, suggesting an overall good study quality (Table 2).

thumbnail
Download:
Table 1. Characteristics of the included studies.

https://doi.org/10.1371/journal.pone.0307428.t001

thumbnail
Download:
Table 2. Study quality evaluation via the Newcastle–Ottawa Scale.

https://doi.org/10.1371/journal.pone.0307428.t002

Results of the meta-analysis

Since four of the included studies reported the outcome in men and women separately [21, 22, 30, 32], these datasets were independently included, which meant there were 20 datasets from 16 studies available for the meta-analysis. The pooled results with a random-effects model showed that prediabetes was associated with a higher prevalence of depression in this population (OR: 1.16, 95% CI: 1.05 to 1.28, p = 0.003; I2 = 58%; Fig 2).

thumbnail
Download:
Fig 2. Forest plots for the meta-analysis of the association between prediabetes and depression.

https://doi.org/10.1371/journal.pone.0307428.g002

Further sensitivity analysis performed by excluding one study at a time showed consistent results (OR: 1.12 to 1.18, p all < 0.05). Further subgroup analysis according to the study country showed similar results (p for subgroup analysis = 0.46; Fig 3A). The subgroup analysis showed a stronger association between prediabetes and depression in younger subjects (<50 years old, OR: 1.25, 95% CI: 1.04 to 1.50) than that in older subjects (≥50 years old, OR: 1.05, 95% CI: 1.10 to 1.10; p for subgroup difference = 0.03; Fig 3B). Other study characteristics, such as the sex of the participants (p for subgroup analysis = 0.44; Fig 4A), definition of prediabetes (p for subgroup analysis = 0.70; Fig 4B), methods used for the detection of depression (p for subgroup analysis = 0.13; Fig 5A), and study quality score (p for subgroup analysis = 0.55; Fig 5B), did not seem to significantly affect the results.

thumbnail
Download:
Fig 3. Forest plots for the subgroup analyses of the association between prediabetes and depression: A, subgroup analysis according to the study country; and B, subgroup analysis according to the age of the subjects.

https://doi.org/10.1371/journal.pone.0307428.g003

thumbnail
Download:
Fig 4. Forest plots for the subgroup analyses of the association between prediabetes and depression: A, subgroup analysis according to the sex of the subjects; and B, subgroup analysis according to the definition of prediabetes.

https://doi.org/10.1371/journal.pone.0307428.g004

thumbnail
Download:
Fig 5. Forest plots for the subgroup analyses of the association between prediabetes and depression: A, subgroup analysis according to the scales used for the diagnosis of depression; and B, subgroup analysis according to the study quality score.

https://doi.org/10.1371/journal.pone.0307428.g005

Publication bias evaluation

The funnel plots for the meta-analysis of the association between prediabetes and depression were symmetrical upon visual inspection, indicating a low risk of publication bias (Fig 6). The results of Egger’s regression test (p = 0.55) also suggested a low risk of publication bias.

thumbnail
Download:
Fig 6. Funnel plots for the meta-analysis of the association between prediabetes and depression.

https://doi.org/10.1371/journal.pone.0307428.g006

Discussion

In this systematic review and meta-analysis, we synthesized the evidence from 16 high-quality observational studies and found that compared to people with normoglycemia, those with prediabetes were associated with a slightly higher prevalence of depression. In addition, subgroup analysis according to age showed that the association between prediabetes and depression may be stronger in younger people <50 years old compared to older people aged over 50 years old. Subgroup analysis according to other study characteristics, such as the study country, sex of the participants, definition of prediabetes, methods used for the diagnosis of depression, and study quality scores, did not significantly change the results. Taken together, the results of the meta-analysis indicate that prediabetes may be associated a slightly higher prevalence of depression in the general population, particularly in subjects aged <50 years old.

To the best of our knowledge, few meta-analyses have been performed to evaluate the association between prediabetes and depression. Although, one early meta-analysis that included five observational studies suggested that impaired glucose metabolism was not associated with the development of depressive symptoms [17]. However, due to the limited number of available studies, no subgroup analysis could be performed. Compared to the previous meta-analysis, this current study has a few methodological strengths to highlight. First, an extensive literature search was performed in three commonly used electronic databases, which retrieved 16 large-scale high-quality studies according to the aim of the meta-analysis. We only included large-scale studies with a sample size of at least 1000 to minimize the potential bias that can arise in small-scale studies. In addition, because depression is closely related to somatic diseases and multimorbidity [40], we focused on the general population, and excluded patients with specific diagnoses of diseases to avoid the confounding effects of comorbidities. Moreover, all of the included studies used multivariate analysis when the association between prediabetes and depression was determined, with adjustment for age, sex, and related socioeconomic status, which could minimize the confounding effects of these factors. Finally, multiple sensitivity and subgroup analyses were performed, and returned consistent results, further validating the robustness of the findings. Collectively, these results highlight the association between glycemic metabolism disorders in the development of depression symptoms, which may occur in prediabetes, even before the diagnosis of diabetes.

There are several hypotheses regarding the mechanisms underlying the association between prediabetes and depression. Persistent mildly hyperglycemia in prediabetes has been linked to chronic inflammation and oxidative stress [41], which has also been revealed in the pathogenesis of affective disorders, such as depression [42]. In addition, it has also been suggested that hyperglycemia and hyperinsulinemia in prediabetes could lead to neuroendocrine changes, which may finally stimulate the development of depression [43]. Moreover, similar to type 2 diabetes [44], prediabetes is also associated with cerebral microvascular dysfunction, which is also associated with a higher risk of depression [45]. However, it has to be mentioned that the above hypotheses have been rarely investigated in preclinical or clinical studies, and efforts are still needed to clarify the potential mechanisms underlying the association between prediabetes and depression.

The association between diabetes and depression is considered to be bidirectional [9–11]. Similarly, it is important to determine if the association between prediabetes and depression is also bidirectional. If the hypothesis is confirmed, this bidirectional relationship could suggest that there may be shared underlying mechanisms linking these two conditions, such as inflammation, hypothalamic-pituitary-adrenal axis dysregulation, and lifestyle factors. Furthermore, understanding this bidirectional relationship can inform future research directions and interventions aimed at preventing and managing both prediabetes and depression.

This study also has some limitations to note. First, all of the included studies were cross-sectional studies, which could not aid determining whether prediabetes is a risk factor for the development of depression. Prospective studies are needed in the future to address this issue. Secondly, the meta-analysis protocol was not registered in advance, which could affect the transparency of the methods. Thirdly, the definition of prediabetes and the diagnostic methods for depression varied among the included studies, which may be an important source of heterogeneity. However, as far as we know, the optimal definition of prediabetes and scale for evaluating depression remain to be established. Moreover, although the results were based on the data from multivariate analysis, we could not exclude the possibility that there are still unadjusted factors that may confound the association between prediabetes and depression, such as dietary and nutritional factors. For example, vitamin D deficiency has been related to both prediabetes [46] and depression [47], which therefore may confound the association between prediabetes and depression in the general population. In addition, other confounding factors such as family history, the presence of other comorbid conditions that might predispose to depression and life events need to be considered, especially given the cross-sectional nature of the studies included. However, since these factors were generally not reported in the included studies, we could not determine if they might have affected the results of the meta-analysis. Finally, the results of the meta-analysis showed that prediabetes is only associated with a mildly increased prevalence of depression, the clinical relevance of which remains to be determined.

Conclusions

As a summary, results of the meta-analysis indicate that the prevalence of depression is slightly increased in people with prediabetes compared to those with normoglycemia, particularly in younger participants <50 years old. Large-scale prospective cohort studies are needed to determine if prediabetes is a risk factor for depression in general population.

Acknowledgments

We thank Medjaden Inc. for scientific editing of this manuscript.

References

  1. 1. Sampogna G, Toni C, Catapano P, Rocca BD, Di Vincenzo M, Luciano M, et al. New trends in personalized treatment of depression. Curr Opin Psychiatry. 2024;37(1):3–8. pmid:37865845
  2. 2. DeJean D, Giacomini M, Vanstone M, Brundisini F. Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013;13(16):1–33. pmid:24228079
  3. 3. Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: A systematic review and meta-analysis. J Affect Disord. 2017;22136–46. pmid:28628766
  4. 4. Wang H, Akbari-Alavijeh S, Parhar RS, Gaugler R, Hashmi S. Partners in diabetes epidemic: A global perspective. World J Diabetes. 2023;14(10):1463–1477. pmid:37970124
  5. 5. Owens-Gary MD, Zhang X, Jawanda S, Bullard KM, Allweiss P, Smith BD. The Importance of Addressing Depression and Diabetes Distress in Adults with Type 2 Diabetes. J Gen Intern Med. 2019;34(2):320–324. pmid:30350030
  6. 6. Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015;75(6):577–587. pmid:25851098
  7. 7. Pashaki MS, Mezel JA, Mokhtari Z, Gheshlagh RG, Hesabi PS, Nematifard T, et al. The prevalence of comorbid depression in patients with diabetes: A meta-analysis of observational studies. Diabetes Metab Syndr. 2019;13(6):3113–3119. pmid:31790965
  8. 8. Buchberger B, Huppertz H, Krabbe L, Lux B, Mattivi JT, Siafarikas A. Symptoms of depression and anxiety in youth with type 1 diabetes: A systematic review and meta-analysis. Psychoneuroendocrinology. 2016;7070–84. pmid:27179232
  9. 9. Alzoubi A, Abunaser R, Khassawneh A, Alfaqih M, Khasawneh A, Abdo N. The Bidirectional Relationship between Diabetes and Depression: A Literature Review. Korean J Fam Med. 2018;39(3):137–146. pmid:29788701
  10. 10. Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev. 2011;31(8):1239–1246. pmid:21963669
  11. 11. Bruce DG. Relationship between type 2 diabetes and risk of depression is bi-directional. Evid Based Ment Health. 2011;14(2):46. pmid:21502152
  12. 12. Graham EA, Deschenes SS, Khalil MN, Danna S, Filion KB, Schmitz N. Measures of depression and risk of type 2 diabetes: A systematic review and meta-analysis. J Affect Disord. 2020;265224–232. pmid:32090745
  13. 13. Colagiuri S. Definition and Classification of Diabetes and Prediabetes and Emerging Data on Phenotypes. Endocrinol Metab Clin North Am. 2021;50(3):319–336. pmid:34399948
  14. 14. Rett K, Gottwald-Hostalek U. Understanding prediabetes: definition, prevalence, burden and treatment options for an emerging disease. Curr Med Res Opin. 2019;35(9):1529–1534. pmid:30935247
  15. 15. Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S. Diagnosis and Management of Prediabetes: A Review. JAMA. 2023;329(14):1206–1216. pmid:37039787
  16. 16. Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370m2297. pmid:32669282
  17. 17. Tong A, Wang X, Li F, Xu F, Li Q, Zhang F. Risk of depressive symptoms associated with impaired glucose metabolism, newly diagnosed diabetes, and previously diagnosed diabetes: a meta-analysis of prospective cohort studies. Acta Diabetol. 2016;53(4):589–598. pmid:26923701
  18. 18. Knol MJ, Heerdink ER, Egberts AC, Geerlings MI, Gorter KJ, Numans ME, et al. Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med. 2007;69(4):300–305. pmid:17470664
  19. 19. Paile M, Raikkonen K, Forsen T, Kajantie E, Yliharsila H, Salonen MK, et al. Depression and its association with diabetes, cardiovascular disease, and birth weight. Ann Med. 2007;39(8):634–640. pmid:17852029
  20. 20. Aujla N, Abrams KR, Davies MJ, Taub N, Skinner TC, Khunti K. The prevalence of depression in white-European and South-Asian people with impaired glucose regulation and screen-detected type 2 diabetes mellitus. PLoS One. 2009;4(11):e7755. pmid:19898618
  21. 21. Holt RI, Phillips DI, Jameson KA, Cooper C, Dennison EM, Peveler RC. The relationship between depression and diabetes mellitus: findings from the Hertfordshire Cohort Study. Diabet Med. 2009;26(6):641–648. pmid:19538241
  22. 22. Bouwman V, Adriaanse MC, van ’t Riet E, Snoek FJ, Dekker JM, Nijpels G. Depression, anxiety and glucose metabolism in the general dutch population: the new Hoorn study. PLoS One. 2010;5(4):e9971. pmid:20376307
  23. 23. Gale CR, Kivimaki M, Lawlor DA, Carroll D, Phillips AC, Batty GD. Fasting glucose, diagnosis of type 2 diabetes, and depression: the Vietnam experience study. Biol Psychiatry. 2010;67(2):189–192. pmid:19892320
  24. 24. Poongothai S, Anjana RM, Pradeepa R, Ganesan A, Umapathy N, Mohan V. Prevalence of depression in relation to glucose intolerance in urban south Indians—the Chennai Urban Rural Epidemiology Study (CURES-76). Diabetes Technol Ther. 2010;12(12):989–994. pmid:21128845
  25. 25. Tsai CH, Wu JS, Chang YF, Lu FH, Yang YC, Chang CJ. The relationship between psychiatric symptoms and glycemic status in a Chinese population. J Psychiatr Res. 2012;46(7):927–932. pmid:22608774
  26. 26. Natasha K, Hussain A, Azad Khan AK, Bhowmik B. Prevalence of Depression and Glucose Abnormality in an Urbanizing Rural Population of Bangladesh. Diabetes Metab J. 2015;39(3):218–229. pmid:26124992
  27. 27. Sun JC, Xu M, Lu JL, Bi YF, Mu YM, Zhao JJ, et al. Associations of depression with impaired glucose regulation, newly diagnosed diabetes and previously diagnosed diabetes in Chinese adults. Diabet Med. 2015;32(7):935–943. pmid:25439630
  28. 28. Albertorio JR, Eberhardt MS, Oquendo M, Mesa-Frias M, He Y, Jonas B, et al. Depressive states among adults with diabetes: Findings from the National Health and Nutrition Examination Survey, 2007–2012. Diabetes Res Clin Pract. 2017;12780–88.
  29. 29. Breyer MK, Ofenheimer A, Altziebler J, Hartl S, Burghuber OC, Studnicka M, et al. Marked differences in prediabetes- and diabetes-associated comorbidities between men and women-Epidemiological results from a general population-based cohort aged 6–80 years-The LEAD (Lung, hEart, sociAl, boDy) study. Eur J Clin Invest. 2019;50(3):e13207.
  30. 30. Cui N, Cui J, Xu X, Aslam B, Bai L, Li D, et al. Health Conditions, Lifestyle Factors and Depression in Adults in Qingdao, China: A Cross-Sectional Study. Front Psychiatry. 2021;12508810. pmid:34054589
  31. 31. Xu J, Bian Z, Zhang Y, Pan J, Gao F, Wang C, et al. Depressive symptoms in Chinese adults with risk factors for diabetes: the Shanghai High-Risk Diabetic Screen (SHiDS) study. Diabet Med. 2021;38(5):e14375. pmid:32745282
  32. 32. de Ritter R, Sep SJS, van der Kallen CJH, van Greevenbroek MMJ, Koster A, Eussen S, et al. Sex comparisons in the association of prediabetes and type 2 diabetes with cognitive function, depression, and quality of life: The Maastricht study. Diabet Med. 2023;40(7):e15115. pmid:37052591
  33. 33. Yang YL, Im EO, Kim Y. Association between type 2 diabetes mellitus and depression among Korean midlife women: a cross-sectional analysis study. BMC Nurs. 2023;22(1):237. pmid:37430288
  34. 34. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372n71.
  35. 35. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372n160. pmid:33781993
  36. 36. Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2. The Cochrane Collaboration. 2021;www.training.cochrane.org/handbook.
    • 37. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010;http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
      • 38. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. pmid:12111919
      • 39. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. pmid:9310563
      • 40. Triolo F, Harber-Aschan L, Belvederi Murri M, Calderon-Larranaga A, Vetrano DL, Sjoberg L, et al. The complex interplay between depression and multimorbidity in late life: risks and pathways. Mech Ageing Dev. 2020;192111383. pmid:33045250
      • 41. Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2019;70(6). pmid:32084643
      • 42. Sipahi H, Mat AF, Ozhan Y, Aydin A. The Interrelation between Oxidative Stress, Depression and Inflammation through the Kynurenine Pathway. Curr Top Med Chem. 2023;23(6):415–425. pmid:36567285
      • 43. Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diabetes Rev. 2007;3(4):252–259. pmid:18220683
      • 44. Marseglia A, Fratiglioni L, Kalpouzos G, Wang R, Backman L, Xu W. Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: A population-based cohort study. Alzheimers Dement. 2019;15(1):25–33. pmid:30114414
      • 45. van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8(4):325–336. pmid:32135131
      • 46. Pojednic RM, Trussler EM, Navon JD, Lemire SC, Siu EC, Metallinos-Katsaras ES. Vitamin D deficiency associated with risk of prediabetes among older adults: Data from the National Health and Nutrition Examination Survey (NHANES), 2007–2012. Diabetes Metab Res Rev. 2022;38(3):e3499. pmid:34590783
      • 47. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013;202100–107. pmid:23377209